Miguel Skirzewski

Miguel Skirzewski

Auto-generated profile, based on publicly available information

Miguel Skirzewski

Robarts Research Institute, Schulich School of Medicine and Dentistry, Western University, London, Canada

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 June 2018 in Nature Neuroscience
Verified
Journal Article
Open access
PDF file
BBB. Sofia Beas
B. Sofia Beas
BWBrandon J. Wright
Brandon J. Wright
MSMiguel Skirzewski
Miguel Skirzewski
YLYan Leng
Yan Leng
JHJung Ho Hyun
Jung Ho Hyun
MPMario A. Penzo
Mario A. Penzo
The paraventricular nucleus of the thalamus (PVT) is increasingly being recognized as a critical node linking stress detection to the emergence of adaptive behavioral responses to stress. However, despite growing evidence implicating the PVT in stress processing, the neural mechanisms by which stress impacts PVT neurocircuitry and promotes stressed states remain unknown. Here we show that stress exposure drives a rapid and persistent reduction of inhibitory transmission onto projection neurons of the posterior PVT (pPVT). This stress-induced disinhibition of the pPVT was associated with a locus coeruleus-mediated rise in the extracellular concentration of dopamine in the midline thalamus, required the function of dopamine D2 receptors on PVT neurons, and increased sensitivity to stress. Our findings define the locus coeruleus as an important modulator of PVT function: by controlling the inhibitory tone of the pPVT, it modulates the excitability of pPVT projection neurons and controls stress responsivity.

1 February 2017 in Cell Metabolism
Verified
Journal Article
Closed access
DFDanielle M. Friend
Danielle M. Friend
KDKavya Devarakonda
Kavya Devarakonda
TOTimothy J. O’nEal
Timothy J. O’nEal
MSMiguel Skirzewski
Miguel Skirzewski
IPIoannis Papazoglou
Ioannis Papazoglou
AKAlexxai V. Kravitz
Alexxai V. Kravitz

26 April 2018 in PLOS Genetics
Verified
Journal Article
Open access
PDF file
RPRaffaella De Pace
Raffaella De Pace
MSMiguel Skirzewski
Miguel Skirzewski
MDMarkus Damme
Markus Damme
RMRafael Mattera
Rafael Mattera
JMJeffrey Mercurio
Jeffrey Mercurio
JBJuan S Bonifacino
Juan S Bonifacino
The hereditary spastic paraplegias (HSP) are a clinically and genetically heterogeneous group of disorders characterized by progressive lower limb spasticity. Mutations in subunits of the heterotetrameric (ε-β4-μ4-σ4) adaptor protein 4 (AP-4) complex cause an autosomal recessive form of complicated HSP referred to as “AP-4 deficiency syndrome”. In addition to lower limb spasticity, this syndrome features intellectual disability, microcephaly, seizures, thin corpus callosum and upper limb spasticity. The pathogenetic mechanism, however, remains poorly understood. Here we report the characterization of a knockout (KO) mouse for the AP4E1 gene encoding the ε subunit of AP-4. We find that AP-4 ε KO mice exhibit a range of neurological phenotypes, including hindlimb clasping, decreased motor coordination and weak grip strength. In addition, AP-4 ε KO mice display a thin corpus callosum and axonal swellings in various areas of the brain and spinal cord. Immunohistochemical analyses show that the transmembrane autophagy-related protein 9A (ATG9A) is more concentrated in the trans-Golgi network (TGN) and depleted from the peripheral cytoplasm both in skin fibroblasts from patients with mutations in the μ4 subunit of AP-4 and in various neuronal types in AP-4 ε KO mice. ATG9A mislocalization is associated with increased tendency to accumulate mutant huntingtin (HTT) aggregates in the axons of AP-4 ε KO neurons. These findings indicate that the AP-4 ε KO mouse is a suitable animal model for AP-4 deficiency syndrome, and that defective mobilization of ATG9A from the TGN and impaired autophagic degradation of protein aggregates might contribute to neuroaxonal dystrophy in this disorder. Hereditary spastic paraplegia (HSP) is a genetic disorder characterized by progressive stiffness of the legs. To date, mutations in more than 70 genes have been shown to cause HSP. Four of these genes encode the subunits of adaptor protein 4 (AP-4), a heterotetrameric complex involved in intracellular protein trafficking. AP-4 deficiency belongs to a subset of complicated HSPs featuring intellectual disability, seizures, microcephaly and thinning of the corpus callosum in addition to leg stiffness. Here we describe the characteristics of mice lacking the expression of the ε subunit of AP-4. These mice exhibit motor deficits consistent with those seen in the human patients. In addition, they have an abnormally thin corpus callosum and defective axons in various parts of the brain and the spinal cord. Importantly, fibroblasts from AP-4 deficient patients as well as neurons from AP-4 deficient mice fail to deliver the autophagy-related protein 9A (ATG9A) from the Golgi complex to the cell periphery. This defect is associated with accumulation of abnormal protein aggregates in axons from AP-4-deficient neurons. We conclude that AP-4 mutant mice are a suitable animal model for studies of AP-4 deficiency in humans, and that altered localization of ATG9A and aggregate formation in neurons likely contribute to the development of the disease.

21 March 2017 in Molecular Psychiatry
Verified
Journal Article
Open access
PDF file
LYL Yan
L Yan
ASA Shamir
A Shamir
MSM Skirzewski
M Skirzewski
ELElias Leiva-Salcedo
Elias Leiva-Salcedo
OKO B Kwon
O B Kwon
ABAndres Buonanno
Andres Buonanno
Numerous genetic and functional studies implicate variants of Neuregulin-1 (NRG1) and its neuronal receptor ErbB4 in schizophrenia and many of its endophenotypes. Although the neurophysiological and behavioral phenotypes of NRG1 mutant mice have been investigated extensively, practically nothing is known about the function of NRG2, the closest NRG1 homolog. We found that NRG2 expression in the adult rodent brain does not overlap with NRG1 and is more extensive than originally reported, including expression in the striatum and medial prefrontal cortex (mPFC), and therefore generated NRG2 knockout mice (KO) to study its function. NRG2 KOs have higher extracellular dopamine levels in the dorsal striatum but lower levels in the mPFC; a pattern with similarities to dopamine dysbalance in schizophrenia. Like ErbB4 KO mice, NRG2 KOs performed abnormally in a battery of behavioral tasks relevant to psychiatric disorders. NRG2 KOs exhibit hyperactivity in a novelty-induced open field, deficits in prepulse inhibition, hypersensitivity to amphetamine, antisocial behaviors, reduced anxiety-like behavior in the elevated plus maze and deficits in the T-maze alteration reward test—a task dependent on hippocampal and mPFC function. Acute administration of clozapine rapidly increased extracellular dopamine levels in the mPFC and improved alternation T-maze performance. Similar to mice treated chronically with N-methyl-d-aspartate receptor (NMDAR) antagonists, we demonstrate that NMDAR synaptic currents in NRG2 KOs are augmented at hippocampal glutamatergic synapses and are more sensitive to ifenprodil, indicating an increased contribution of GluN2B-containing NMDARs. Our findings reveal a novel role for NRG2 in the modulation of behaviors with relevance to psychiatric disorders.

20 July 2017 in Molecular Psychiatry
Verified
Journal Article
Open access
PDF file
MSM Skirzewski
M Skirzewski
IKI Karavanova
I Karavanova
ASA Shamir
A Shamir
LEL Erben
L Erben
JGJ Garcia-Olivares
J Garcia-Olivares
ABAndres Buonanno
Andres Buonanno
Genetic variants of Neuregulin 1 (NRG1) and its neuronal tyrosine kinase receptor ErbB4 are associated with risk for schizophrenia, a neurodevelopmental disorder characterized by excitatory/inhibitory imbalance and dopamine (DA) dysfunction. To date, most ErbB4 studies have focused on GABAergic interneurons in the hippocampus and neocortex, particularly fast-spiking parvalbumin-positive (PV+) basket cells. However, NRG has also been shown to modulate DA levels, suggesting a role for ErbB4 signaling in dopaminergic neuron function. Here we report that ErbB4 in midbrain DAergic axonal projections regulates extracellular DA levels and relevant behaviors. Mice lacking ErbB4 in tyrosine hydroxylase-positive (TH+) neurons, but not in PV+ GABAergic interneurons, exhibit different regional imbalances of basal DA levels and fail to increase DA in response to local NRG1 infusion into the dorsal hippocampus, medial prefrontal cortex and dorsal striatum measured by reverse microdialysis. Using Lund Human Mesencephalic (LUHMES) cells, we show that NRG/ErbB signaling increases extracellular DA levels, at least in part, by reducing DA transporter (DAT)-dependent uptake. Interestingly, TH-Cre;ErbB4f/f mice manifest deficits in learning, spatial and working memory-related behaviors, but not in numerous other behaviors altered in PV-Cre;ErbB4f/f mice. Importantly, microinjection of a Cre-inducible ErbB4 virus (AAV-ErbB4.DIO) into the mesencephalon of TH-Cre;ErbB4f/f mice, which selectively restores ErbB4 expression in DAergic neurons, rescues DA dysfunction and ameliorates behavioral deficits. Our results indicate that direct NRG/ErbB4 signaling in DAergic axonal projections modulates DA homeostasis, and that NRG/ErbB4 signaling in both GABAergic interneurons and DA neurons contribute to the modulation of behaviors relevant to psychiatric disorders.

24 December 2022 in Nature Communications
Verified
Journal Article
Open access
PDF file
MSMiguel Skirzewski
Miguel Skirzewski
OPOren Princz-Lebel
Oren Princz-Lebel
LGLiliana German-Castelan
Liliana German-Castelan
ACAlycia M. Crooks
Alycia M. Crooks
GKGerard Kyungwook Kim
Gerard Kyungwook Kim
TBTimothy J. Bussey
Timothy J. Bussey
The ability to learn Pavlovian associations from environmental cues predicting positive outcomes is critical for survival, motivating adaptive behaviours. This cued-motivated behaviour depends on the nucleus accumbens (NAc). NAc output activity mediated by spiny projecting neurons (SPNs) is regulated by dopamine, but also by cholinergic interneurons (CINs), which can release acetylcholine and glutamate via the activity of the vesicular acetylcholine transporter (VAChT) or the vesicular glutamate transporter (VGLUT3), respectively. Here we investigated behavioural and neurochemical changes in mice performing a touchscreen Pavlovian approach task by recording dopamine, acetylcholine, and calcium dynamics from D1- and D2-SPNs using fibre photometry in control, VAChT or VGLUT3 mutant mice to understand how these signals cooperate in the service of approach behaviours toward reward-predicting cues. We reveal that NAc acetylcholine-dopaminergic signalling is continuously updated to regulate striatal output underlying the acquisition of Pavlovian approach learning toward reward-predicting cues.